LIVE

ARGX

argenx SE

ARGX

NASDAQ·Healthcare·Biotechnology·Mkt cap $57.1B

$898.07

-2.19%

52-Week Range

$590.78 - $953.58

P/E

Fwd P/E

24.67

Beta

-0.02

Div Yield

0.00%

Avg Vol

343.6K

Shares Out

Mkt Cap

$57.1B

Price action

Price chart

Up 54.3% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

No bull reasons captured for this rating yet.

Bear Case

2 risks

  • Low volatility (beta 0.0).
  • Premium valuation to sector peers

Growth

Revenue decline expected

Value

Premium valuation to sector peers

Momentum

Strong

+17.2% over 3m

Quality

Excellent

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Jul 23, 2026

LATEST RECAP

Earnings recap unavailable for this period.

EPS surprise · last 4Q

No quarterly earnings data on file.

Next: Jul 23, 2026

Wall Street consensus

11 analysts · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

11

100%

Hold

0%

Sell

0%

Median Price Target

$1,238.50

+37.9% vs $898.07

Low $1,135.00
Median $1,238.50
High $1,291.00

Latest: Oppenheimer · Jul 24, 2026

4 analysts covering

vs Industry

How ARGX stacks vs Biotechnology

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.

Related

Peers & themes

Peers

No peer data available.

Themes

No themes assigned.